Iodohippurate Sodium I-123
Generic Name: iodohippurate sodium i-123
Manufactured by GE HEALTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODOHIPPURATE SODIUM I-123 (1mCi/ML). Application: NDA018289.
Overview
Manufactured by GE HEALTHCARE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IODOHIPPURATE SODIUM I-123 (1mCi/ML). Application: NDA018289.
Dosage
Available as injectable for injection use.
Related Medications
Lidocaine, Petrolatum
lidocaine, petrolatum
Amide Local Anesthetic [EPC]
PURPOSE Anesthetic Skin Protectant
Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed, Hepatitis B (recombinant) And Inactivated Poliovirus Vaccine Combined
diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis b (recombinant) and inactivated poliovirus vaccine combined
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (25 ug/.5mL); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED) (8 ug/.5mL); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED) (25 ug/.5mL); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) (10 [iU]/.5mL); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) (25 [iU
Reishi Yeast Fu Ling Ophiopogon Japonicus Whole
reishi yeast fu ling ophiopogon japonicus whole
Non-Standardized Fungal Allergenic Extract [EPC]
INHIBITING BACTERIAL GROWTH AND PROMOTING METABOLIC EXCRETION
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.